Novela ECL is a multiple Bacillus strain DFM selected from the intestinal mucosa of high performing monogastrics. In addition
to their ability to colonize, these Bacillus strains were selected for a wide range of functional characteristics, such as antimicrobial capabilities, immunomodulation, and ability to produce enzymes.
